Placental site trophoblastic tumor (PSTT)

Placental site trophoblastic tumor (PSTT), also known as atypical choriocarcinoma, syncytioma, chorioepitheliosis or trophoblastic pseudotumor, is a rare gestational trophoblastic disease (0.25-5% of all trophoblastic tumors) and it is composed by neoplastic proliferation of intermediate trophoblast...

ver descrição completa

Detalhes bibliográficos
Autores: Zampacorta, Claudia, Pasciuto, Maria Paola, Ferro, Benedetta, Lucidi, Alessandro|||0000-0002-8454-4878, Sánchez Maestro, Ángel, Espinosa, Iñigo|||0009-0007-0818-1191, D'Angelo, Emanuela|||0000-0002-6173-1806, Prat, Jaime|||0000-0002-9787-3304
Formato: artículo
Fecha de publicación:2023
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:302829
Acesso em linha:https://ddd.uab.cat/record/302829
https://dx.doi.org/urn:doi:10.32074/1591-951X-873
Access Level:acceso abierto
Palavra-chave:HPL
Intermediate trophoblast
Gestational trophoblastic disease
Placental site trophoblastic tumor
Descrição
Resumo:Placental site trophoblastic tumor (PSTT), also known as atypical choriocarcinoma, syncytioma, chorioepitheliosis or trophoblastic pseudotumor, is a rare gestational trophoblastic disease (0.25-5% of all trophoblastic tumors) and it is composed by neoplastic proliferation of intermediate trophoblasts at placental implantation site. It consists of aggregates or sheets of large, polyhedral to round, predominantly mononucleated cells with a characteristic vascular and myometrial invasion. Main differential diagnoses are gestational choriocarcinoma (GC) and epitelioid trophoblastic tumor (ETT). We present a case of PSTT in a 25-year-old woman. Neoplastic cells showed moderate/high nuclear pleomorphism, abundant amphophilic, eosinophilic and clear cytoplasm, numerous mitotic figures (10 mitoses/10 HPF), and myometrial invasion. Other features are necrosis, vascular invasion with replacement of myometrial vessels by tumor cells and hemorrhage. The patient showed typical low serum β-hCG levels and high serum humane placental lactogen (hPL) levels.